tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market

Artiva Biotherapeutics, Inc. (ARTV) Financial Statements

Compare
17 Followers

Artiva Biotherapeutics, Inc. Financial Overview

Artiva Biotherapeutics, Inc.'s market cap is currently $92.06M. The company's EPS TTM is $; its P/E ratio is ―; Artiva Biotherapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 33.49M$ 4.93M$ 2.00M$ 0.00
Gross Profit$ 33.49M$ 4.93M$ 2.00M$ 0.00
Operating Income$ -30.67M$ -59.83M$ -53.27M$ -18.27M
EBITDA$ -28.41M$ -58.67M$ -71.58M$ -17.72M
Net Income$ -27.70M$ -58.39M$ -71.83M$ -17.99M
Balance Sheet
Cash & Short-Term Investments$ 76.97M$ 102.53M$ 160.92M$ 25.44M
Total Assets$ 105.11M$ 133.05M$ 169.93M$ 29.23M
Total Debt$ 16.91M$ 19.45M$ 1.74M$ 2.12M
Net Debt$ -36.59M$ -83.08M$ -159.18M$ -23.33M
Total Liabilities$ 267.13M$ 273.75M$ 258.78M$ 50.80M
Stockholders' Equity$ -162.01M$ -140.70M$ -88.86M$ -21.57M
Cash Flow
Free Cash Flow$ -50.69M$ -57.13M$ -17.03M$ -13.82M
Operating Cash Flow$ -47.43M$ -50.83M$ -15.30M$ -13.54M
Investing Cash Flow$ -25.98M$ -6.30M$ -1.72M$ -284.00K
Financing Cash Flow$ 24.39M$ -1.26M$ 152.75M$ 37.40M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History

Artiva Biotherapeutics, Inc. Debt to Assets

Artiva Biotherapeutics, Inc. Cash Flow

Artiva Biotherapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis